Notizia - Recent Pharma, Healthcare and Biotech Happenings

A biotech company Novome Biotechnologies is developing novel live medicines for chronic diseases, has raised USD 33 Million in Series A financing. The financing was led by DCVC Bio with participation from seed investor 5AM Ventures, Alta Partners, Alexandria Venture Investments and Mayo Clinic. The company plans to use the funds to advance the Company’s lead hyperoxaluria program and to expand its Genetically Engineered Microbial Medicines (GEMMs) platform.  The company is developing a robust pipeline to treat chronic diseases that invades the human gut. The pivotal program of the company is focusing on advancing the treatment approach for hyperoxaluria.&n...